SCHEMBL1521860

SCHEMBL1521860

CC(C)(C)CCCC#N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11955052 0.92 TSHR (0.46)
SCHEMBL14002143 0.89 TSHR (0.43)
SCHEMBL12933281 0.89 TSHR (0.43)
SCHEMBL14907 0.81
SCHEMBL13617233 0.79 TSHR (0.40)
SCHEMBL8851469 0.78
SCHEMBL6648740 0.78 TSHR (0.43)
SCHEMBL12707552 0.78 TSHR (0.43)
SCHEMBL26318516 0.76 TSHR (0.48)
SCHEMBL26535341 0.75 TSHR (0.45)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 69 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110272514-A A kind of brominated isobutylene-p-methylstyrene copolymer and preparation method thereof 黄河三角洲京博化工研究院有限公司 2019-09-24 CN claimed
CN-105601779-A Process for direct halogenation of poly(p-methyl styrene-CO-isobutylene) prepared with solution method BEIJING INSTITUTE PETROCHEMICAL TECHNOLOGY 2016-05-25 CN claimed
CN-1225648-A Process for halogenation of isomonoolefin/para-alkylstyrene copolymers EXXON CHEMICAL PATENTS INC (US) 1999-08-11 CN claimed
CN-1225649-A Improved process for halogenating isomonoolefin copolymers EXXON CHEMICAL PATENTS INC (US) 1999-08-11 CN claimed
US-20230372537-A1 LIPID NANOPARTICLE FORMULATIONS ACUITAS THERAPEUTICS INC (CA) 2023-11-23 US disclosed
US-11795170-B2 Therapeutic compounds, compositions and methods of use thereof GENENTECH, INC. (US) 2023-10-24 US disclosed
US-11771715-B2 Circular RNA compositions and methods ORNA THERAPEUTICS, INC. (US) 2023-10-03 US disclosed
US-11766449-B2 Circular RNA compositions and methods ORNA THERAPEUTICS, INC. (US) 2023-09-26 US disclosed
US-11712481-B2 Lipid nanoparticle formulations Acuitas Therapeutics, Inc. (CA) 2023-08-01 US disclosed
US-20230235365-A1 ENGINEERED RETRONS AND METHODS OF USE RENAGADE THERAPEUTICS MANAGEMENT INC. (US) 2023-07-27 US disclosed
US-20230226096-A1 CIRCULAR RNA COMPOSITIONS AND METHODS ORNA THERAPEUTICS, INC. 2023-07-20 US disclosed
US-11679120-B2 Circular RNA compositions and methods ORNA THERAPEUTICS, INC. (US) 2023-06-20 US disclosed
US-7442718-B2 Inhibitors of aspartyl protease VERTEX PHARMACEUTICALS INCORPORATED (US) 2008-10-28 US disclosed
US-20070149569-A1 Methods of treating amyloidosis using cyclopropyl derivative aspartyl protease inhibitors ELAN PHARMACEUTICALS, INC. 2007-06-28 US disclosed
US-20070149569-A1 Methods of treating amyloidosis using cyclopropyl derivative aspartyl protease inhibitors ELAN PHARMACEUTICALS, INC. 2007-06-28 US disclosed
WO-2007047305-A1 METHODS OF TREATING AMYLOIDOSIS USING CYCLOPROPYL DERIVATIVE ASPARTYL PROTEASE INHIBITORS ELAN PHARMACEUTICALS, INC. (US) 2007-04-26 WO disclosed
WO-2007047305-A1 METHODS OF TREATING AMYLOIDOSIS USING CYCLOPROPYL DERIVATIVE ASPARTYL PROTEASE INHIBITORS ELAN PHARMACEUTICALS, INC. (US) 2007-04-26 WO disclosed
EP-1754705-A2 Antagonists for treatment of CD11/CD18 adhesion receptor mediated disorders Genentech, Inc. (US) 2007-02-21 EP disclosed
EP-1053220-B1 IMPROVED SEPARATION PROCESSES UNION CARBIDE CHEM PLASTIC (US) 2005-02-23 EP disclosed
CN-1225648-A Process for halogenation of isomonoolefin/para-alkylstyrene copolymers EXXON CHEMICAL PATENTS INC (US) 1999-08-11 CN disclosed